Trial ChiCTR2000031809
Publication Xia S, JAMA, 2020
Primary outcome on the report: Injection siteĀ–specific adverse reactions andsystemic adverse reactions within 7 days of each injection and the neutralizing antibody titers and the specific IgG-binding antibody titers